Respiratory Parameters Using Advanced Airways During In-hospital Cardiac Arrest
Launched by ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST · Aug 29, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how much air is delivered to the lungs during resuscitation attempts in patients who experience cardiac arrest while in the hospital. The goal is to compare the effectiveness of different airway devices used by healthcare providers to help these patients breathe. To do this, a special device will measure the amount of air delivered in real time as rescuers give breaths. This trial is part of a larger study called AIRWAYS-3, which looks at how different airway methods affect the outcomes of patients who suffer cardiac arrest in the hospital.
To be eligible for this trial, participants must be experiencing cardiac arrest in the hospital and require advanced airway management, as determined by a trained clinician. However, those who had a cardiac arrest outside the hospital, are not current hospital patients, or are already using certain breathing tubes will not be included. If eligible, participants can expect to receive standard care for cardiac arrest, while their breathing support will be monitored to gather important data for improving future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * As per AIRWAYS-3 trial:
- • In-hospital cardiac arrest, attended by the hospital cardiac arrest team in response to a cardiac arrest call (2222 or equivalent), and when a clinician permitted to undertake both tracheal intubation and supraglottic airway placement (so that either intervention can be delivered) is present
- • Undergoing resuscitation and requiring advanced airway management in the opinion of the trained clinician responsible for randomisation
- Exclusion Criteria:
- • As per AIRWAYS-3 trial
- • Patients who have a cardiac arrest outside hospital and who are transported to the hospital in ongoing cardiac arrest
- • People who are not a hospital inpatient (e.g. visitor, relative, staff or outpatient)
- • Patients who are already tracheally intubated at the time of eligibility assessment
- • Patients known to be pregnant
- • Patients with a functioning tracheostomy
About Royal United Hospitals Bath Nhs Foundation Trust
Royal United Hospitals Bath NHS Foundation Trust is a leading healthcare provider in the United Kingdom, dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust is committed to fostering innovation in clinical practices through robust research initiatives. It collaborates with various stakeholders, including academic institutions and industry partners, to promote evidence-based medicine and improve health outcomes. The Trust's research portfolio encompasses a wide range of therapeutic areas, reflecting its mission to enhance patient care through scientific discovery and application.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bath, Banes, United Kingdom
Patients applied
Trial Officials
Kelly Spencer
Study Chair
Royal United Hosptial Bath
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported